ALYSSA ARAGOSA: Open Payments
NPI 1982063434 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 22 payments from 16 companies in 2025. Trend: 2023 $770 · 2024 $331 · 2025 $701
Food & beverage: $458Education: $243
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 2 | $134 |
| SEAGEN INC. | 1 | $100 |
| PFIZER INC. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Astellas Pharma US Inc | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $28 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $27 |
Products named: FOTIVDA, ENHERTU, SCEMBLIX, RYBREVANT, INLYTA, Padcev, NERLYNX, VERZENIO.
Industry payments across NY — which companies pay providers there.
